Joseph Eiden
About
Joseph Eiden is a scholar working on Epidemiology, Infectious Diseases and Microbiology.
According to data from OpenAlex, Joseph Eiden has authored 56 papers receiving a total of 2.5k indexed citations (citations by other indexed papers that have themselves been cited), including 29 papers in Epidemiology, 22 papers in Infectious Diseases and 22 papers in Microbiology. Recurrent topics in Joseph Eiden's work include Bacterial Infections and Vaccines (20 papers), Pneumonia and Respiratory Infections (15 papers) and Viral gastroenteritis research and epidemiology (10 papers). Joseph Eiden is often cited by papers focused on Bacterial Infections and Vaccines (20 papers), Pneumonia and Respiratory Infections (15 papers) and Viral gastroenteritis research and epidemiology (10 papers). Joseph Eiden collaborates with scholars based in United States, United Kingdom and Canada. Joseph Eiden's co-authors include Gary Van Nest, Scott A. Halperin, Bruce R. Smith, Annaliesa S. Anderson, Henry Li, Robert Lindblad, A.P. Khattignavong, David H. Broide, John T. Schroeder and Susan Balcer-Whaley and has published in prestigious journals such as New England Journal of Medicine, Blood and Clinical Infectious Diseases.
In The Last Decade
Joseph Eiden
56 papers receiving 2.3k citations
Peers — A (Enhanced Table)
Peers by citation overlap · career bar shows stage (early→late) cites · hero ref
| Name | h | Career | Trend | Papers | Cites | |||||
|---|---|---|---|---|---|---|---|---|---|---|
| Joseph Eiden United States | 24 | 774 | 740 | 587 | 569 | 560 | 56 | 2.5k | ||
| Jana Eckert Germany | 17 | 337 0.4× | 728 1.0× | 216 0.4× | 285 0.5× | 119 0.2× | 25 | 1.7k | ||
| Eduardo López Argentina | 25 | 442 0.6× | 229 0.3× | 203 0.3× | 608 1.1× | 236 0.4× | 85 | 1.7k | ||
| R. H. Waldman United States | 29 | 919 1.2× | 803 1.1× | 182 0.3× | 447 0.8× | 190 0.3× | 70 | 2.3k | ||
| C C Kuo United States | 40 | 2.9k 3.8× | 1.3k 1.7× | 736 1.3× | 535 0.9× | 4.5k 8.0× | 72 | 5.7k | ||
| K Schopfer Switzerland | 21 | 1.5k 1.9× | 274 0.4× | 139 0.2× | 1.3k 2.3× | 105 0.2× | 46 | 2.4k | ||
| Maria Antonia De Francesco Italy | 23 | 621 0.8× | 513 0.7× | 58 0.1× | 311 0.5× | 227 0.4× | 98 | 1.7k | ||
| G. Cozon France | 20 | 462 0.6× | 489 0.7× | 56 0.1× | 604 1.1× | 40 0.1× | 57 | 1.8k | ||
| P.A.C. Maple United Kingdom | 23 | 829 1.1× | 145 0.2× | 55 0.1× | 602 1.1× | 421 0.8× | 59 | 1.7k | ||
| A. Fleer Netherlands | 26 | 502 0.6× | 389 0.5× | 123 0.2× | 724 1.3× | 222 0.4× | 66 | 2.1k | ||
| L Å Hanson Sweden | 23 | 656 0.8× | 247 0.3× | 106 0.2× | 191 0.3× | 90 0.2× | 40 | 1.6k |
Countries citing papers authored by Joseph Eiden
Since
Specialization
Citations
This map shows the geographic impact of Joseph Eiden's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Joseph Eiden with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Joseph Eiden more than expected).
Fields of papers citing papers by Joseph Eiden
Since
Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences
This network shows the impact of papers produced by Joseph Eiden. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Joseph Eiden. The network helps show where Joseph Eiden may publish in the future.
Co-authorship network of co-authors of Joseph Eiden
This figure shows the co-authorship network connecting the top 25 collaborators of Joseph Eiden. A scholar is included among the top collaborators of Joseph Eiden based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Joseph Eiden. Joseph Eiden is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
1.
Beeslaar, Johannes, Susan Mather, Judith Absalon, et al.. (2022). Safety data from the MenB-FHbp clinical development program in healthy individuals aged 10 years and older. Vaccine. 40(12). 1872–1878.
2.
Beeslaar, Johannes, Paula Peyrani, Judith Absalon, et al.. (2020). Sex, Age, and Race Effects on Immunogenicity of MenB-FHbp, A Bivalent Meningococcal B Vaccine: Pooled Evaluation of Clinical Trial Data. Infectious Diseases and Therapy. 9(3). 625–639.
3.
Marshall, Helen, James Baber, Peter Richmond, et al.. (2019). S. aureus colonization in healthy Australian adults receiving an investigational S. aureus 3-antigen vaccine. Journal of Infection. 79(6). 582–592.
4.
Begier, Elizabeth, David Seiden, Michael A. Patton, et al.. (2017). SA4Ag, a 4-antigen Staphylococcus aureus vaccine, rapidly induces high levels of bacteria-killing antibodies. Vaccine. 35(8). 1132–1139.
5.
Frenck, Robert W., C. Buddy Creech, Eric Sheldon, et al.. (2016). Safety, tolerability, and immunogenicity of a 4-antigen Staphylococcus aureus vaccine (SA4Ag): Results from a first-in-human randomised, placebo-controlled phase 1/2 study. Vaccine. 35(2). 375–384.
6.
Marshall, Helen, Michael D. Nissen, Peter Richmond, et al.. (2016). Safety and immunogenicity of a booster dose of a 3-antigen Staphylococcus aureus vaccine (SA3Ag) in healthy adults: A randomized phase 1 study. Journal of Infection. 73(5). 437–454.
7.
Dayan, Gustavo H., Naglaa Mohamed, Ingrid L. Scully, et al.. (2016). Staphylococcus aureus: the current state of disease, pathophysiology and strategies for prevention. Expert Review of Vaccines. 15(11). 1373–1392.
8.
Richmond, Peter, Helen Marshall, Michael D. Nissen, et al.. (2012). Safety, immunogenicity, and tolerability of meningococcal serogroup B bivalent recombinant lipoprotein 2086 vaccine in healthy adolescents: a randomised, single-blind, placebo-controlled, phase 2 trial. The Lancet Infectious Diseases. 12(8). 597–607.
9.
Corash, Laurence, Jin Lin, Claire D. Sherman, & Joseph Eiden. (2010). Determination of acute lung injury after repeated platelet transfusions. Blood. 117(3). 1014–1020.
10.
Tulić, Meri K., Pota Christodoulopoulos, Pierre Fiset, et al.. (2009). Local Induction of a Specific Th1 Immune Response by Allergen Linked Immunostimulatory DNA in the Nasal Explants of Ragweed- Allergic Subjects. Allergology International. 58(4). 565–572.
11.
Creticos, Peter S., John T. Schroeder, Robert G. Hamilton, et al.. (2006). Immunotherapy with a Ragweed–Toll-Like Receptor 9 Agonist Vaccine for Allergic Rhinitis. New England Journal of Medicine. 355(14). 1445–1455.
12.
Halperin, Scott A., Simon Dobson, Shelly McNeil, et al.. (2005). Comparison of the safety and immunogenicity of hepatitis B virus surface antigen co-administered with an immunostimulatory phosphorothioate oligonucleotide and a licensed hepatitis B vaccine in healthy young adults. Vaccine. 24(1). 20–26.
13.
Tulić, Meri K., Pierre Fiset, Pota Christodoulopoulos, et al.. (2004). Amb a 1–immunostimulatory oligodeoxynucleotide conjugate immunotherapy decreases the nasal inflammatory response. Journal of Allergy and Clinical Immunology. 113(2). 235–241.
14.
Ward, Richard L., David I. Bernstein, Vicki E. Smith, et al.. (2004). Rotavirus Immunoglobulin A Responses Stimulated by Each of 3 Doses of a Quadrivalent Human/Bovine Reassortant Rotavirus Vaccine. The Journal of Infectious Diseases. 189(12). 2290–2293.
15.
Clark, H. F., David I. Bernstein, Penelope H. Dennehy, et al.. (2004). Safety, efficacy, and immunogenicity of a live, quadrivalent human-bovine reassortant rotavirus vaccine in healthy infants. The Journal of Pediatrics. 144(2). 184–190.
16.
Halperin, Scott A., et al.. (2003). A phase I study of the safety and immunogenicity of recombinant hepatitis B surface antigen co-administered with an immunostimulatory phosphorothioate oligonucleotide adjuvant. Vaccine. 21(19-20). 2461–2467.
17.
Hsu, Tsu‐An, Kathryn M. Carbone, Steven A. Rubin, Steven Vonderfecht, & Joseph Eiden. (1994). Borna Disease Virus p24 and p38/40 Synthesized in a Baculovirus Expression System: Virus Protein Interactions in Insect and Mammalian Cells. Virology. 204(2). 854–859.
18.
Gaydos, C A, Joseph Eiden, David Oldach, et al.. (1994). Diagnosis of Chlamydia pneumoniae Infection in Patients with Community-Acquired Pneumonia by Polymerase Chain Reaction Enzyme Immunoassay. Clinical Infectious Diseases. 19(1). 157–160.
19.
Lindsay, D. A., Steven Vonderfecht, Michael J. Betenbaugh, & Joseph Eiden. (1993). Baculovirus Expression of Gene 6 of the IDIR Strain of Group B Rotavirus (GBR): Coding Assignment of the Major Inner Capsid Protein. Virology. 193(1). 367–375.
20.
Vonderfecht, Steven, et al.. (1986). Identification of a bovine enteric syncytial virus as a nongroup A rotavirus. American Journal of Veterinary Research. 47(9). 1913–1918.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.
Explore authors with similar magnitude of impact
Breakdown of academic impact, for papers by Jana Eckert Breakdown of academic impact, for papers by Eduardo López Breakdown of academic impact, for papers by R. H. Waldman Breakdown of academic impact, for papers by C C Kuo Breakdown of academic impact, for papers by K Schopfer Breakdown of academic impact, for papers by Maria Antonia De Francesco Breakdown of academic impact, for papers by G. Cozon Breakdown of academic impact, for papers by P.A.C. Maple Breakdown of academic impact, for papers by A. Fleer Breakdown of academic impact, for papers by L Å Hanson